Gene Editing Therapeutics Market
Report Scope:
This report highlights the current and future market potential of gene editing therapeutics and provides a detailed analysis of the drivers, restraints and opportunities in this market. It also surveys the competitive environment, including coverage of the pipeline activities adopted by market players, and it includes market projections for 2029. Also included are company profiles of key players, featuring detailed information regarding each company’s business segments, financials, product portfolios and recent developments.
Report Includes:
15 data tables and 42 additional tables
An analysis of the current and future global markets for gene editing therapeutics
Analyses of global market trends, with market revenue data (sales figures) for 2021-2023, estimates for 2024, and projected CAGRs through 2029
Estimates of the market size and revenue forecasts for the global gene editing therapeutics market, with market share analysis by region
Discussion of the market dynamics, opportunities, and challenges, as well as emerging technologies
Overview of sustainability trends and ESG developments in the industry, with emphasis on the ESG practices of leading companies, their ESG rankings, and consumer attitudes
Competitive intelligence, including companies’ market shares, recent M&A activity, and venture funding
Company profiles of major players within the industry, including CRISPR Therapeutics, Vertex Pharmaceuticals, and Intellia Therapeutics
Companies Mentioned
Allogene Therapeutics
Beam Therapeutics
Caribou Biosciences Inc.
Crispr Therapeutics
Editas Medicine
Intellia Therapeutics Inc.
Precision Biosciences
Sangamo Therapeutics
Vertex Pharmaceuticals Inc.
Verve Therapeutics Inc.
Vor Bio
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Introduction
- Genome-Editing Tool Types
- Meganucleases
- Zinc Finger Nucleases
- Transcription Activator-like Effector Nucleases
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
- Gene editing Therapeutics
- Chapter 3 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Increasing Prevalence of Chronic Disease
- Increasing Prevalence of Rare Genetic Disorders
- Precision Medicine
- Increasing Strategic Initiatives
- Market Restraints
- Stringent Regulatory Frameworks and Time-Consuming Approval Processes
- High Cost of Treatment
- Adverse Events and Long-Term Monitoring
- Lack of Skilled Workforce
- Off-Target Impact
- Market Challenges
- Patent Disputes
- Governmental Policies and Regulations
- Ethical Issues
- Market Opportunities
- Chapter 4 Emerging Technologies and Developments
- Introduction
- Base Editing
- Prime Editing
- Cas-Clover and Cas-FOKl
- CRISPR Interference and CRISPR Activation
- RNA Editing
- Artificial Intelligence in Genome Editing
- Chapter 5 Pipeline Analysis
- Overview
- Clinical Trial Analysis Based on Technology
- Clinical Trial Analysis Based on Diseases
- Designations for Pipeline Drugs
- Chapter 6 Patent Analysis
- Chapter 7 Market Analysis
- Introduction
- Casgevy
- Market Overview
- Market Analysis
- Market by Region
- North America
- Europe
- Emerging Markets
- Chapter 8 Competitive Intelligence
- Strategic Initiatives
- Competitive Landscape
- Chapter 9 Sustainability in the Gene Editing Therapeutics Market: Environmental, Social and Governance (ESG) Perspectives
- Introduction
- ESG Practices in the Gene Editing Companies
- Concluding Remarks from BCC Research
- Chapter 10 Appendix
- Methodology
- Sources
- Acronyms
- Company Profiles
- ALLOGENE THERAPEUTICS
- BEAM THERAPEUTICS
- CARIBOU BIOSCIENCES INC.
- CRISPR THERAPEUTICS
- EDITAS MEDICINE
- INTELLIA THERAPEUTICS INC.
- PRECISION BIOSCIENCES
- SANGAMO THERAPEUTICS
- VERTEX PHARMACEUTICALS INC.
- VERVE THERAPEUTICS INC.
- VOR BIO
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook